Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Nyxoah SA (NYXH) Q3 2026 Earnings Call Transcript
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
Here's Why Nyxoah (NYXH) Could be Great Choice for a Bottom Fisher
Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
Contrasting Nephros (NASDAQ:NEPH) & Nyxoah (NASDAQ:NYXH)
Nyxoah: Label Expansion Set To Unlock A Monopoly In A Billion Dollar Market.
Nyxoah Appoints Liam Kelly as Chief Executive Officer
Nyxoah Announces Chief Financial Officer Transition
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial
Nyxoah Annonce l’Implantation du Premier Patient dans BREATHE, l’Étude Post-Approbation Américaine du Système Genio®
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
Nyxoah SA (NYXH) Q2 2026 Earnings Call Transcript
Nyxoah Q2 Earnings Call Highlights
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day
Nyxoah SA (NYXH) Analyst/Investor Day Transcript
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
Information on the total number of voting rights and shares
Publication relating to transparency notifications
Already premium?